The fund received commitments from real estate firms Greystar, Realogy, AvalonBay Communities, Camden Property Trust, JBG Smith and Leading Real Estate Companies of the World.

The multi-corporate-backed biologic pill developer has listed on the Nasdaq Global Market, pricing the shares below their range.

Q&A with Veronica Gabriele, associate, Munich Re Ventures

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

Donald Tucker has joined DocuSign to help run its corporate development and venture investments.

The offering would produce $500m, including up to $70.6m from the sale of new shares, and offer exits to Max Group and TVS.

Intervenn Biosciences was co-founded by faculty members at Stanford University and University of California, Berkeley.

SoftBank and Heritage Provider Network were among the investors who co-led a series C round for Intervenn Biosciences, which is developing precision medicine.

The industrial sensor manufacturer spun out of Michigan and Virginia has increased its latest round to $51m in a tranche backed by 3M, Ericsson and Armstrong International.

Corporate-backed teleconferencing system provider Baijiayun raised cash at a $465m valuation while financial software provider Prime Trust closed a $64m round featuring Nationwide and Samsung Next.